GESSEL advises on yet another LUX MED investment
13.07.2023 Case studies Mergers and acquisitions (M&A) Corporate law
We advised the LUX MED group on yet another investment – this time in Orthos Szpital Wielospecjalistyczny in Komorowice near Wrocław.
Our comprehensive support included due diligence, work on the transaction documentation, and closing of the transaction as well as advice on regulating liability of the parties concerned.
The entire project, both during the due diligence and the transaction stages, was overseen and led on GESSEL’s part by Marcin Macieszczak, managing partner.
The due diligence team was led by Michał Boryczka, managing associate, was composed of Emilia Szkiela, senior associate, Erazm Dutkiewicz, associate, Dominika Lara, senior associate, and Marcin Walczak, associate.
Krzysztof Jasiński, managing associate, was in charge of the transaction work, with the support of Marcin Walczak, associate.
The real estate aspect of the project was supervised by Maciej Boryczko, partner, heading the team composed of Iwona Gielo-Benza, associate, and Walentyna Okun, associate.
The LUX MED Group is a leader in the private healthcare services sector in Poland. It is a part of the international Bupa Group, which operates as an insurer and provider of medical services worldwide.
Orthos is a hospital located in Komorowice near Wrocław, providing a wide range of diagnostic, therapeutic, and rehabilitation services. The hospital performs medical procedures in various fields, including orthopaedics and traumatology of the musculoskeletal system, plastic surgery, general and oncologic surgery, gynaecology, otolaryngology, and neurosurgery.
Lawyers involved in the project
Marcin Macieszczak
Managing partner
Attorney-at-law
Mergers and acquisitions (M&A) | Private Equity
Marcin Walczak
Senior Associate
Attorney-at-law
Mergers and acquisitions (M&A) | Corporate law
Erazm Dutkiewicz
Senior Associate
Attorney-at-law
Corporate law | Life Sciences and Health Care
You may also like
21.04.2026
GESSEL advises Lux Med on acquisition of TMS Diagnostyka
GESSEL advised Lux Med sp. z o.o., a leading private healthcare provider in Poland, on the acquisition of 100% of the shares in TMS Diagnostyka sp. z o.o., a Poland base...
20.04.2026
GESSEL advised Creotech Instruments on the spin-off of its quantum business and the WSE listing of Creotech Quantum
GESSEL advised Creotech Instruments S.A. on the spin-off of its quantum business and the listing of Creotech Quantum S.A. on the Main Market of the Warsaw Stock Exchange...